News
The FDA is amplifying an effort underway at medical device distributor Medline that aims to correct certain neurosurgery kits ...
Digostics, a biotech developing the world's first at-home oral glucose tolerance test for diabetes, has raised £520,474 and counting from 108 investors on crowdfunding platform Crowdcube.
Mammalian HCP ELISA Kits represent a useful technology in biopharmaceutical quality control processes. They can detect and quantify residual host cell proteins that may contaminate biological products ...
Overview of Cell Dissociation MarketThe global Cell Dissociation Market is valued at USD 620 Million in 2024 and is projected ...
You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...
Indo-Italian Innovation Hub powers expansion, academic synergy & talent exchange in Karnataka: Nandita Vijayasimha, Bengaluru Tuesday, July 22, 2025, 08:00 Hrs [IST] Karnataka pha ...
Komfo Anokye Teaching Hospital (KATH) is one of the sites where the the global RECOVERY Trial is being conducted. Enrollment has increased following the introduction of rapid test kits that detect ...
Studies suggest that some commercially available health tests are inaccurate and unsuitable for public use. Rebecca Coombes , Hristio Boytchev , and Gareth Iacobucci ask if regulation is adequately ...
Key Points - Revenue rose 3.0 % year over year to $10.85 billion, surpassing analyst expectations.- Non-GAAP earnings per ...
Analysis of Nucleic Acid Extraction System Market Covering 30 Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GC ...
"At the core of Korean beauty is the skin barrier—nourishing and ensuring that it is not compromised. The Korean skincare ...
1d
Pharmaceutical Technology on MSNSanofi to acquire Vicebio’s share capital for $1.15bn upfrontSanofi has signed an agreement to acquire Vicebio’s share capital for $1.15bn upfront, to expand its vaccine development capabilities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results